Nanocrystalline hydroxyapatite and zinc-doped hydroxyapatite as carrier material for controlled delivery of ciprofloxacin

3 Biotech

Volumn 1, Issue 3, 2011, Pages 173-186

  Venkatasubbu, G Devanand ^a   Ramasamy, S ^a   Ramakrishnan, V ^b   Kumar, J ^a  

^a ANNA UNIVERSITY   (India)

^b MADURAI KAMARAJ UNIVERSITY   (India)

Author keywords

Biomaterials; Ciprofloxacin; Controlled release; Drug delivery; Hydroxyapatite; Pseudomonas aeruginosa; Staphylococcus aureus

Indexed keywords

CIPROFLOXACIN; DRUG CARRIER; HYDROXYAPATITE; NANOCARRIER; UNCLASSIFIED DRUG; ZINC DOPED HYDROXYAPATITE;

ANTIBACTERIAL ACTIVITY; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG LOADING; DRUG STRUCTURE; EXCIPIENT COMPATIBILITY; IN VITRO STUDY; NONHUMAN; PARTICLE SIZE; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 85200168724     PISSN: 2190572X     EISSN: 21905738     Source Type: Journal    
DOI: 10.1007/s13205-011-0021-9     Document Type: Article

References (48)

1. Akashi A, Matsuya Y, Unemori M, Akamine A (2001) Release profile of antimicrobial agents from a-tricalcium phosphate cement. Biomaterials 22:1717-2713
2. Baker R (1987) Controlled release of biologically active agents. Wiley-Interscience, New York, pp 27-29
3. Bandyopadhyay A, Withey EA, Susmita Bose J (2007) Influence of Zno doping in Calcium phosphate ceramics. Mater Sci Eng C 27:14-17
4. Cheng X, Kuhn L (2007) Chemotherapy drug delivery from calcium phosphate nanoparticles. Int J Nanomed 2(4):667-674
5. Chouhan R, Bajpai AK (2010) Release dynamics of ciprofloxacin from swellable nanocarriers of poly(2-hydroxyethyl methacrylate): an in vitro study. NanomedicineNBM 6:453-462
6. Chouhan R, Bajpal AK (2009) An in vitro release study of 5-flurouracil (5-FU) from swellable poly-(2-hydroxyethyl methacrylate) (PHEMA) nanoparticles. J Mater Sci Mater Med 20:1103-1114
7. de Araujo TS, Macedo ZS, de Oliveira PASC, Valerio MEG (2007) Production and characterization of pure and Cr3?-doped hydroxyapatite for biomedical applications as fluorescent probes. J Mater Sci 42:2236-2243
8. De Gaetano F, Ambrosio L, Raucci MG, Marotta A, Catauro M (2005) Sol-gel processing of drug delivery materials and release kinetics. J Mater Sci Mater Med 16:261-265
9. De Jong WH, Borm PJA (2008) Drug delivery and nanoparticles: applications and hazards. Int J Nanomed 3(2):133-149
10. Gautier H, Daculsi G, Merle C (2001) Association of vancomycin and calcium phosphate by dynamic compaction: in vitro characterization and micribiological activity. Biomaterials 22:2481-2487
11. Gibson IR, Best SM, Bonfield W (1999) Chemical characterization of silicon-substituted hydroxyapatite. J Biomed Mater Res 44:422-428
12. Ginebra MP, Traykova T, Planell JA (2006) Calcium phosphate cements as bone drug delivery systems: a review. J Controlled Release 113:102-110
13. Harris LG, Geoff Richards R (2006) Staphylococci and implant surfaces: a review. Injury. Int J Care Injured 37:S3-S14
14. Ito A et al (2002) Zinc-releasing calcium phosphate for stimulating bone formation. Mater Sci Eng C 22(1):21-25
15. Itokazu M, Esaki M, Yamamoto K, Tanemori T, Kasai T (1999) Local drug delivery system using ceramics:vacuum method for impregnating a chemotherapeutic agent into a porous hydroxyapatite block. J Mater Sci Mater Med 10:249-252
16. Jallot E, Nedelec J-M, Grimault AS, Chassot E, Grandjean-Laquerriere A, Laquerriere P, Laurent-Maquin D (2005) STEM and EDXS characterisation of physico-chemical reactions at the periphery of sol-gel derived Zn-substituted hydroxyapatites during interaction with biological fluids, Colloids Surf Biointerfaces 42:205-210
17. Joosten U, Joist A, Gosheger G, Liljenqvist U, Brandt B, von Eiff C (2005) Effectiveness of hydroxyapatite-vancomucin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis. Biomaterials, 26:5251-5258
18. Kim H-W, Knowles JC, Kim H-E (2004) Hydroxyapatite/poly(ecarprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery. Biomaterials 25:1279-1287
19. Koort JK, Makinen TJ, Suokas E, Veiranto M, Jalava J, Tormala P, Aro HT (2008) Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant. Acta Orthop 79(2):295-301
20. Liu WC, Wong CT, Fong MK, Cheung WS, Kao RY, Luk KD, Lu WW (2010) Gentamicin-loaded strontium-containing hydroxyapatite bioactive bone cement-an efficient bioactive antibiotic drug delivery system. J Biomed Mater Res B Appl Biomater 9:397-406
21. Loo SCJ, Siew YE, Ho S, Yin Chiang Boey F (2008) Synthesis and hydrothermal treatment of nanostructured hydroxyapatite of controllable sizes. J Mater Sci Mater Med 19:1389-1397
22. Mason P (2006) Physiological and medicinal zinc. Pharm J 276:271-274
23. Matsunaga K, Murata H, Mizoguchi T, Nakahira A (2010) Mechanism of incorporation of zinc into hydroxyapatite. Acta Biomater 6(6):2289-2293
24. Melville AJ, Rodriguez-Lorenzo LM, Forsythe JS (2008) Effects of calcinations temperature on the drug delivery behavior of ibuprofen from hydroxyapatite powders. J Mater Sci Mater Med 19:1187-1195
25. Murugan R, Panduranga Rao K (2002) Controlled release of antibiotics from surface modified coralline hydroxyapatite. Trends Biomat Artif Organs 16(1):43-45
26. Murugan R, Ramakrishna S (2006) Designing biological apatite suitable for neomycin delivery. J Mater Sci 41(13):4343-4347
27. Nandi SK, Mukherjee P, Roy S, Kundu B, Kumar De D, Basu D (2009) Local antibiotic delivery systems for the treatment of osteomyelitis-A review. Mater Sci Eng C 29(8):2478-2485
28. Noel SP, Courtney H, Bumgardner JD, Haggard WO (2008) Chitosan films a potential local drug delivery system for antibiotics. Clin Orthopaed Related Res 466:1377-1382
29. Norris P, Noble M, Francolini I, Vinogradov AM, Stewart PS, Ratner BD, Costerton JW, Stoodley P (2005) Ultrasonically controlled release of ciprofloxacin from self-assembled Coatings on poly(2-hydroxyethyl methacrylate) hydrogels for Pseudomonasaeruginosa biofilm prevention. Antimicrob Agents Chemother 49:4272-4279
30. Ochekpe NA, Olorunfemi PO, Ngwuluka NC (2009) Nanotechnology and drug delivery part 2: nanostructures for drug delivery. Trop J Pharm Res 8(3):275-287
31. Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissues. Adv Drug Deliv Rev 55:329-347
32. Pataquiva Mateus AY, Ferraz MP, Monteiro FJ (2007) Microspheres based on hydroxyapatite nanoparticles aggregates for bone regeneration. Key Eng Mater 330-332, 243-246
33. Patel SA, Patel NM, Patel MM (2006) Simultaneous spectrophotometric estimation of ciprofloxacin and ornidazole in tablets. Indian J Pharm Sci 68(5):665-667
34. Paul W, Sharma CP (1999) Development of porous spherical hydroxyapatite granules: application towards protein delivery. J Mater Sci Materiald Med 10:383-388
35. Pham HH, Luo P, Genin F, Dash AK (2002) Synthesis and characterization of hydroxyapatite-ciprofloxacin delivery system by precipitation and spray drying technique. AAPS PharmSci-Tech 3(1):1-9
36. Russoni de Lima I, Machado Coasta A, Napoleao Bastos I (2006) Development and characterization of 5% mol Zn bioceramic in granular form. Mater Res 9:399-403
37. Slosarczyk A, Szymura-Oleksiak J, Mycek B (2000) The kinetics of pentoxifylline from drug loaded hydroxyapatite implants. Biomaterials 21:1215-1221
38. Sogo Y, Ito A, Fukasawa K, Sakurai T, Ichinose N (2004) Zinc containing hydroxyapatite ceramics to promote osteoblastic cell activity. Mater Sci Technol 20(9):1079-1083
39. Somberg JC (1989) Drug delivery system. J Clin Pharmacol 2:673
40. Soriano de Souza CA, Souto APRM, Silva-Boghossian CM, Granjeiro JM, Alves GG, Rossi AM, Rocha-Leao MHM (2011) Adsorption of chlorhexidine on synthetic hydroxyapatite and in vitro biological activity. Colloid Surf B Biointerfaces 87:310-318
41. Stanic V, Dimitrijevic S, Antic-Stankovic J, Mitric M, Jokic B, Plecas IB, Raičevic S (2010) Synthesis, characterization and antimicrobial activity of copper and zinc-doped hydroxyapatite nanopowders. Appl Surf Sci 256:6083-6089
42. Sundar M, Ramesh Babu N, Prem Victor S, Ram Kumar K, Sampath Kumar TS (2005) Biphasic calcium phosphate for antibiotic release. Trends Biomat Artif Organs 18(2): 213-218
43. Szycher M (1986) Controlled drug delivery: a critical review. J Biomater Appl 1:171-182
44. Szymura-Oleksiak J, Slosarczyk A, Cios A, Mycek B, Paszkiewicz Z, Szklarczyk S, Stankiewicz D (2001) The kinetics of pentoxifylline release in vivo from drug-loaded hydroxyapatite implants. Ceram Int 27:767-772
45. Tang Y, Chappell HF, Dove MT, Reeder RJ, Lee YJ (2009a) Zinc incorporation into hydroxyapatite. Biomaterials 30:2864-2872
46. Tang Y, Chappell HF, Dove MT, Reeder RJ, Lee YJ (2009b) Zinc incorporation into hydroxyapatite. Biopmaterials 30:2864-2872
47. Vijayakumar P, Jain NK (2007) Suppression of agglomeration of ciprofloxacin-loaded human serum albumin nanoparticles. AAPS PharmSciTech 8:1-6
48. Zeiler H-J (1985) Evaluation of the in vitro bactericidal action of ciprofloxacin on cells of escherichia coli in the logarithmic and stationary phases of growth. Antimicrob Agents Chemother 28(4):524-527